Long noncoding RNA lncARSR promotes nonalcoholic fatty liver disease and hepatocellular carcinoma by promoting YAP1 and activating the IRS2/AKT pathway. Here, YAP1 is linked to metabolic dysfunction-associated steatotic liver disease.